Tags » Pharma

DRREDDY @4201 on 28/08/2015

You may even now remain out of it and wait till next advice…ref 894+40/1.90 (140/305/1881/1350/1105/3m).

Prev Advice:

DRREDDY @3631 on 22/05/2015

Since last advice was to retain it for medium term you might well have sold it as it touched high of 3800/- since the time of advice @3182 on 03/11/2014, you may remain out of it now and wait for next advice…ref 916+40/3250/3800 (161/363/1677/1350/1030). 12 more words

Stock-specific Recommendations

Corner offices vacant in pharma industry

The consolidation and steady growth witnessed in the over Rs 90,000-crore domestic pharma market have led to openings in top leadership roles with at least three drug companies on the lookout for CEOs. 429 more words

Antal International

Global Protein Engineering Market: Growing Prevalence of Chronic Diseases to Boost Development of Drugs through Protein Engineering

Protein engineering refers to designing new enzymes or proteins with desirable properties. The process is based on the use of recombinant DNA technology to change amino acid sequences. 626 more words

Market Research Report

Is it affordable for patient access to keep apace with Pharma innovation?

FDA approvals for for bio pharmaceuticals hit a ten year high in 2014 with 41 new molecular entities being approved1. Progress in pharma is undoubtedly good news for society, but for patients to reap the dividends of therapeutic innovation, it is nearly as arduous a process as the R & D journey in itself – even in the rich, developed world. 350 more words


New book discussing Flibanserin: 'Big Pharma, Women, and the Labour of Love'

There has been a lot of discussion recently about Flibanserin. In fact, I’m probably going to write something myself about about it over the next few days. 404 more words

Biolab cruza fronteiras e vai investir no Canadá

agosto 21, 2015 por clipping para Abiquifi

Stella Fontes – Valor Econômico:

O grupo farmacêutico brasileiro Biolab acaba de dar o pontapé inicial em sua estratégia de internacionalização.  641 more words


Meet the innovator: Brendan Woods, Almac Group

Brendan has over 20 years’ experience in the delivery of software solutions to some of the world’s largest companies covering many sectors including financial and pharmaceutical supply chain.  433 more words